Here are relevant reports on : education-administration-market
-
Europe Enteral Feeding Devices Market by Type [Tubes(Nasal, Gastrostomy), Pumps {Portable, Stationary}, Enteral Syringe, Administration Set, Consumable], Insertion Method, Age Group (Neonate, Pediatric, Geriatric), Application, End user- Forecast to 2032
The Europe enteral feeding device market, valued at USD 0.85 billion in 2025, stood at USD 0.88 billion in 2026 and is projected to advance at a resilient CAGR of 4.0% from 2026 to 2032, culminating in a forecasted valuation of USD 1.11 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Student Information System Market by Platform Module (Academic Management, Financial Management, Communication & Engagement, Core Student Administration (Student Record Management, Timetable Management, Attendance Tracking)) - Global Forecast to 2029
The global student information system market size is projected to reach USD 32.04 billion by 2029 at a compounded annual growth rate (CAGR) of 15.9% during the forecast period. Some of the significant student information system vendors include Oracle (US), Workday (US), Ellucian (US), PowerSchool (US), Jenzabar (US), Skyward (US), SAP (Germany), Anthology (US), Veracross (US), and Blackbaud (US).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
US Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type [Workforce, CIAM, 82B], Identity Type [Human, Non-human]-Forecast to 2030
The identity and access management (IAM) market in the US is expected to expand significantly, rising from USD 7.34 billion in 2025 to USD 11.09 billion by 2030 at a CAGR of 8.6%. The key players include Microsoft (US), Ping Identity (US), IBM (US), Okta (US), Oracle (US), SailPoint (US), Saviynt (US), CyberArk (US), Akamai Technologies (US), Entrust (US), RSA Security (US), Avatier (US), ManageEngine (US), SecureAuth (US), EmpowerID (US), Simeio (US), One Identity (US), FusionAuth (US), Auth0 (US), and Zuora (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Migraine Drugs Market by Product Type (Acute migraine treatment, Preventive migraine treatment), Route of administration (Oral, Injection, and Others), and End User (Hospital pharmacies, Retail pharmacies, Online pharmacies) - Global Forecast to 2023
The global Migrane Drugs market is expected to reach USD 3.96 billion by 2023 from USD 1.95 million in 2018, growing at a CAGR of 15.2%. Increasing awareness about novel therapies, launch of Calcitonin Gene-related Peptide (CGRP), increasing incidence of migraines and launch of new drugs are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new drugs, thus propelling the market growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral)- Global Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Property Management Market by Software Type (Lease Management (Portfolio Management, Document Storage & Management, AI Lease Abstraction, Lease Accounting & Administration), Facility Management, Reporting & Analytics), End User - Global Forecast to 2030
The property management market size is projected to reach USD 42.78 billion by 2030, at a CAGR of 8.3% during the forecast period. Some major players in the property management market include Oracle (US), IBM (US), Appfolio (US), SAP (Germany), Hitachi Vantara (US), Yardi (US), RealPage (US), SS&C (US), Trimble (US), Eptura (US), CoStar Group (US), Hemlane (US), Entrata (US), Rent Manager (US), Rentec Direct (US), Re-leased (UK), Doorloop (US), Stessa (US), JLL (US), MCS Rental Software (UK), Accruent (US), Planon (Netherlands), Guesty (Israel), Hive (Germany), Avail (Sweden), Property Matrix (US), HappyCo (US), Resman (US), Innago (US), Finquery (US), Rentredi (US), Turbotenant (US), Breezeway (US), Livly (US), SimplifyEm (US), Condo Control (US) and PayHOA (US)
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
Records 21 to 30 of 50
